DEXCOM INC
Institutional investors holding DXCM
| Investor | Weight | Quarter |
|---|---|---|
| Stephen Mandel | 2.66% | 2021Q3 |
| Chase Coleman | 0.60% | 2024Q2 |
| Glenn Welling | 0.36% | 2017Q3 |
| Meridian / ArrowMark | 0.33% | 2019Q2 |
| Viking Global Investors | 0.15% | 2016Q1 |
| Kenneth Fisher | 0.00% | 2026Q1 |
| First Eagle Investment Management | 0.00% | 2026Q1 |
Congressional data coming soon
20
Total trades
$1.9M
Volume
10
Buys
10
Sells
Last trade: Jun 3, 2026
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Jon Coleman | Sell | $359K |
| Jun 3, 2026 | Jon Coleman | Sell | $364K |
Congressional trade data is being sourced and will appear here shortly.
| May 28, 2026 |
| Kyle Malady |
| Buy |
| – |
| May 28, 2026 | Kyle Malady | Buy | – |
| May 28, 2026 | Kyle Malady | Buy | – |
| May 28, 2026 | Steven R Altman | Buy | – |
| May 28, 2026 | Nicholas Augustinos | Buy | – |
| May 28, 2026 | Euan A. Ashley | Buy | – |
| May 28, 2026 | Kyle Malady | Buy | – |
| May 28, 2026 | Richard Alexander Collins | Buy | – |
| May 28, 2026 | Kyle Malady | Buy | – |
| May 28, 2026 | Kyle Malady | Buy | – |
| May 22, 2026 | Michael Jon Brown | Sell | $104K |
| May 22, 2026 | Jon Coleman | Sell | $529K |
| May 22, 2026 | Kyle Malady | Sell | $104K |
| May 22, 2026 | Kyle Malady | Sell | $104K |
| May 22, 2026 | Kyle Malady | Sell | $104K |
| May 15, 2026 | Michael Jon Brown | Sell | $102K |
| May 12, 2026 | Kyle Malady | Sell | $61K |